Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Lam Research (LRCX) Asset Writedowns and Impairment (2018)

Lam Research has reported Asset Writedowns and Impairment over the past 4 years, most recently at $42.5 million for Q1 2018.

For Q1 2018, Asset Writedowns and Impairment changed N/A year-over-year to $42.5 million; the TTM value through Jun 2019 reached $42.5 million, changed 0.0%, while the annual FY2018 figure was $42.5 million, N/A changed from the prior year.
Asset Writedowns and Impairment for Q1 2018 was $42.5 million at Lam Research, up from $4.0 million in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $42.5 million in Q1 2018 and troughed at $4.0 million in Q1 2014.